AtriCure, Inc.

NasdaqGM:ATRC 株式レポート

時価総額：US$1.1b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

AtriCure マネジメント

マネジメント 基準チェック /24

AtriCure'sの CEO はMike Carrelで、 Nov2012年に任命され、 の在任期間は 11.58年です。 の年間総報酬は$ 8.75Mで、 9.2%給与と90.8%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の1.37%を直接所有しており、その価値は$ 13.91M 。経営陣と取締役会の平均在任期間はそれぞれ7.3年と7.3年です。

主要情報

Mike Carrel

最高経営責任者

US$8.7m

報酬総額

CEO給与比率9.2%
CEO在任期間11.6yrs
CEOの所有権1.4%
経営陣の平均在職期間7.3yrs
取締役会の平均在任期間7.3yrs

経営陣の近況

Recent updates

AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 88% Above Its Share Price

May 30
AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 88% Above Its Share Price

Positive Sentiment Still Eludes AtriCure, Inc. (NASDAQ:ATRC) Following 29% Share Price Slump

Apr 04
Positive Sentiment Still Eludes AtriCure, Inc. (NASDAQ:ATRC) Following 29% Share Price Slump

Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet?

Mar 14
Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet?

Investors Interested In AtriCure, Inc.'s (NASDAQ:ATRC) Revenues

Jan 21
Investors Interested In AtriCure, Inc.'s (NASDAQ:ATRC) Revenues

Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?

Nov 29
Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?

AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 99% Above Its Share Price

Sep 27
AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 99% Above Its Share Price

Health Check: How Prudently Does AtriCure (NASDAQ:ATRC) Use Debt?

Aug 02
Health Check: How Prudently Does AtriCure (NASDAQ:ATRC) Use Debt?

AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Matching Investor Opinion

Jun 15
AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Matching Investor Opinion

Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?

Apr 14
Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?

Calculating The Intrinsic Value Of AtriCure, Inc. (NASDAQ:ATRC)

Mar 02
Calculating The Intrinsic Value Of AtriCure, Inc. (NASDAQ:ATRC)

What Does AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Indicate?

Feb 09
What Does AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Indicate?

Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?

Dec 28
Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?

Is Now An Opportune Moment To Examine AtriCure, Inc. (NASDAQ:ATRC)?

Sep 06
Is Now An Opportune Moment To Examine AtriCure, Inc. (NASDAQ:ATRC)?

An Intrinsic Calculation For AtriCure, Inc. (NASDAQ:ATRC) Suggests It's 29% Undervalued

Aug 02
An Intrinsic Calculation For AtriCure, Inc. (NASDAQ:ATRC) Suggests It's 29% Undervalued

AtriCure: 5x Sales For A Series Of Impeding Losses? No Thanks

Jun 13

Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?

Jun 08
Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?

Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)?

May 08
Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)?

Is AtriCure, Inc. (NASDAQ:ATRC) Expensive For A Reason? A Look At Its Intrinsic Value

Apr 11
Is AtriCure, Inc. (NASDAQ:ATRC) Expensive For A Reason? A Look At Its Intrinsic Value

Is AtriCure (NASDAQ:ATRC) A Risky Investment?

Feb 18
Is AtriCure (NASDAQ:ATRC) A Risky Investment?

Why AtriCure, Inc. (NASDAQ:ATRC) Could Be Worth Watching

Jan 20
Why AtriCure, Inc. (NASDAQ:ATRC) Could Be Worth Watching

CEO報酬分析

AtriCure の収益と比較して、Mike Carrel の報酬はどのように変化したか？
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$37m

Dec 31 2023US$9mUS$804k

-US$30m

Sep 30 2023n/an/a

-US$25m

Jun 30 2023n/an/a

-US$28m

Mar 31 2023n/an/a

-US$38m

Dec 31 2022US$8mUS$795k

-US$46m

Sep 30 2022n/an/a

-US$56m

Jun 30 2022n/an/a

US$53m

Mar 31 2022n/an/a

US$52m

Dec 31 2021US$8mUS$766k

US$50m

Sep 30 2021n/an/a

US$45m

Jun 30 2021n/an/a

-US$57m

Mar 31 2021n/an/a

-US$49m

Dec 31 2020US$6mUS$718k

-US$48m

Sep 30 2020n/an/a

-US$46m

Jun 30 2020n/an/a

-US$50m

Mar 31 2020n/an/a

-US$46m

Dec 31 2019US$6mUS$740k

-US$35m

Sep 30 2019n/an/a

-US$23m

Jun 30 2019n/an/a

-US$20m

Mar 31 2019n/an/a

-US$17m

Dec 31 2018US$4mUS$714k

-US$21m

Sep 30 2018n/an/a

-US$20m

Jun 30 2018n/an/a

-US$20m

Mar 31 2018n/an/a

-US$27m

Dec 31 2017US$4mUS$671k

-US$27m

報酬と市場: Mikeの 総報酬 ($USD 8.75M ) は、 US市場 ($USD 3.37M ) の同規模の企業の平均を上回っています。

報酬と収益: Mikeの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Mike Carrel (53 yo)

11.6yrs

在職期間

US$8,749,289

報酬

Mr. Michael H. Carrel, also known as Mike, serves as the Chief Executive Officer and President at AtriCure, Inc. since November 2012. Mr. Carrel has been Director at Axonics Inc. since February 27, 2019 an...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Michael Carrel
CEO, President & Director11.6yrsUS$8.75m1.37%
$ 15.1m
Angela Wirick
Chief Financial Officer3.8yrsUS$2.92m0.29%
$ 3.2m
Douglas Seith
Chief Operating Officer9.4yrsUS$3.50m0.32%
$ 3.5m
Salvatore Privitera
Chief Technical Officer7.4yrsUS$2.13m0.21%
$ 2.4m
Karl Dahlquist
Chief Legal Officer5.3yrsUS$2.13m0.11%
$ 1.2m
Vinayak Doraiswamy
Chief Scientific Officer7.3yrsUS$1.78m0.12%
$ 1.3m
Valerie Storch-Willhaus
Vice President of Corporate Marketing & Communicationsno dataデータなしデータなし
Justin Noznesky
Chief Marketing & Strategy Officer8.3yrsUS$1.78m0.15%
$ 1.6m
Deborah Yount
Chief Human Resources Officer2yrsUS$1.92m0.098%
$ 1.1m

7.3yrs

平均在職期間

53yo

平均年齢

経験豊富な経営陣: ATRCの経営陣は経験豊富で経験豊富です（平均在職期間は7.3年）。

取締役

名称ポジション在職期間報酬所有権
Michael Carrel
CEO, President & Director11.6yrsUS$8.75m1.37%
$ 15.1m
Sven Wehrwein
Independent Director7.6yrsUS$227.47k0.060%
$ 659.7k
B. Johnson
Independent Director7.3yrsUS$264.97k0.092%
$ 1.0m
Shlomi Nachman
Independent Directorless than a yearデータなし0.027%
$ 298.6k
Robert White
Independent Chairman of the Board11.3yrsUS$225.47k0.20%
$ 2.2m
Karen Prange
Independent Director4.5yrsUS$219.97k0.049%
$ 544.9k
Maggie Yuen
Independent Director3yrsUS$209.97k0.026%
$ 283.9k
Regina Groves
Independent Director7.3yrsUS$232.47k0.064%
$ 700.5k
Deborah Telman
Independent Director3yrsUS$212.47k0.035%
$ 382.2k

7.3yrs

平均在職期間

62yo

平均年齢

経験豊富なボード: ATRCの 取締役会 は 経験豊富 であると考えられます ( 7.3年の平均在任期間)。